Caplin Point Laboratories Bilan de santé
Santé financière contrôle des critères 5/6
Caplin Point Laboratories possède un total de capitaux propres de ₹23.5B et une dette totale de ₹19.7M, ce qui porte son ratio d'endettement à 0.08%. Son actif total et son passif total sont ₹27.0B et de ₹3.5B. L'EBIT de Caplin Point Laboratories est ₹5.2B ce qui fait que son ratio de couverture des intérêts 943.1. Elle dispose de liquidités et de placements à court terme de ₹7.9B.
Informations clés
0.08%
Ratio d'endettement
₹19.70m
Dette
| Ratio de couverture des intérêts | 943.1x |
| Argent liquide | ₹7.91b |
| Fonds propres | ₹23.47b |
| Total du passif | ₹3.51b |
| Total des actifs | ₹26.98b |
Mises à jour récentes de la santé financière
Recent updates
With EPS Growth And More, Caplin Point Laboratories (NSE:CAPLIPOINT) Makes An Interesting Case
Oct 31
Caplin Point Laboratories (NSE:CAPLIPOINT) Is Due To Pay A Dividend Of ₹2.50
Sep 12Earnings Update: Here's Why Analysts Just Lifted Their Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Price Target To ₹1,764
Aug 11Caplin Point Laboratories (NSE:CAPLIPOINT) Is Paying Out A Dividend Of ₹2.50
Aug 10Investors Aren't Buying Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Earnings
Jul 12Caplin Point Laboratories (NSE:CAPLIPOINT) Strong Profits May Be Masking Some Underlying Issues
May 24Does Caplin Point Laboratories (NSE:CAPLIPOINT) Deserve A Spot On Your Watchlist?
May 04Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Low P/E No Reason For Excitement
Mar 07With EPS Growth And More, Caplin Point Laboratories (NSE:CAPLIPOINT) Makes An Interesting Case
Oct 24Why We Think The CEO Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) May Soon See A Pay Rise
Sep 15Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹2.50
Aug 11We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise
Sep 23Caplin Point Laboratories' (NSE:CAPLIPOINT) Shareholders Will Receive A Bigger Dividend Than Last Year
Sep 11Is Now The Time To Put Caplin Point Laboratories (NSE:CAPLIPOINT) On Your Watchlist?
Jul 22Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹2.00
May 15A Look At The Intrinsic Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
Jan 21Should You Be Adding Caplin Point Laboratories (NSE:CAPLIPOINT) To Your Watchlist Today?
Oct 20Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹1.50
Sep 17Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹1.50
Sep 03Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Intrinsic Value Is Potentially 28% Above Its Share Price
Aug 27Is Caplin Point Laboratories (NSE:CAPLIPOINT) A Risky Investment?
Jun 12Estimating The Fair Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
Apr 29Does Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Have A Place In Your Dividend Portfolio?
Mar 24Analyse de la situation financière
Passif à court terme: Les actifs à court terme de CAPLIPOINT ( ₹18.9B ) dépassent ses passifs à court terme ( ₹3.3B ).
Passif à long terme: Les actifs à court terme de CAPLIPOINT ( ₹18.9B ) dépassent ses passifs à long terme ( ₹200.1M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: CAPLIPOINT dispose de plus de liquidités que de sa dette totale.
Réduire la dette: Le ratio d'endettement de CAPLIPOINT est passé de 0.05% à 0.08% au cours des 5 dernières années.
Couverture de la dette: La dette de CAPLIPOINT est bien couverte par le flux de trésorerie opérationnel ( 16161.9% ).
Couverture des intérêts: Les paiements d'intérêts de CAPLIPOINT sur sa dette sont bien couverts par l'EBIT ( 943.1 x couverture).